About Signature Immunologics

Signature Immunologics develops innovative biochemical, pharmacological, agricultural and consumer applications based on the immunologic detection of small molecules.

Our technologies include tracking endogenous micromolecules, tracer molecules and therapeutic agents, and biomodification.

Our current products offer scientists a powerful library of probes targeting micromolecules essential to the basic processes of all living cells. Our products are characterized by their molecular specificity: each is optimized for reliable, repeatable quantitative analysis.

Founder Robert Marc pioneered the use of AGB as a visualization probe of ion channel activity and developed Computational Molecular Phenotyping for cellular profiling.

Based in Salt Lake City since 1996, Signature Immunologics is privately held, and debt-free.